Concord Biotech Sets Sights on U.S. Expansion After FDA Green Light

Unknown Apr 02, 2026 950 Views

Concord Biotech Ltd is gearing up for a strategic expansion into the United States, following a major regulatory milestone. The Ahmedabad-based biopharma firm has received an Establishment Inspection Report (EIR) from the U.S. FDA for its Dholka API facility, confirming full compliance and cleari...